The Oorjita day

Friday, 21 November 2025

Read the day in order — the morning call, what happened, and what we made of it.

8:02 AMIST

Quality Over Beta: Why Low-Volatility Stocks Are Beating High-Beta Names

Nifty High Beta 50 has underperformed the market, ending several points below its starting base in relative-performance terms, while Nifty 100 Low Volatility 30 has steadily climbed, and Nifty 50 itself is modestly positive.

7 min read

8:36 AMIST

Market Prabhat

After the Breakout: Can Nifty Hold 26,150 Through Profit-Booking?

Sustainability above 26,150 levels and volume confirmation will determine whether yesterday's breakout has conviction or if profit-booking emerges at psychological 26,200+ zones.

20 min read

3:31 PMIST

Oorjita Anveshan

Mankind Pharma: India's No. 4 Drugmaker, Down 13.5%, Lags Peers on Profitability

Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market value, with a diversified presence across prescription pharmaceuticals, consumer healthcare/OTC, and exports.

87 min read

Quality Over Beta: Why Low-Volatility Stocks Are Beating High-Beta Names

After the Breakout: Can Nifty Hold 26,150 Through Profit-Booking?

Mankind Pharma: India's No. 4 Drugmaker, Down 13.5%, Lags Peers on Profitability

Nifty Closes at 26,192 as Bank Nifty Steadies Near 59,300